Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance
Albireo's stock is up 10% on plans to seek FDA approval for drug for rare disorder
Albireo Pharma Stock (ALBO): Why The Price Increased
5 Beaten Down Biotech Stocks That Could Bounce Big In 2022